WELLS FARGO & COMPANY/MN - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 73 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$44,730
-49.0%
26,006
-42.2%
0.00%
Q2 2023$87,744
+161.5%
44,997
+272.8%
0.00%
Q1 2023$33,552
-19.4%
12,069
+0.1%
0.00%
Q4 2022$41,611
+34.2%
12,061
+0.6%
0.00%
Q3 2022$31,000
+6.9%
11,986
+0.3%
0.00%
Q2 2022$29,000
-91.2%
11,945
-85.1%
0.00%
Q1 2022$331,000
-80.3%
80,242
-38.6%
0.00%
Q4 2021$1,681,000
-29.0%
130,695
-40.3%
0.00%
-100.0%
Q3 2021$2,366,000
+792.8%
219,056
+654.9%
0.00%
Q2 2021$265,000
-22.3%
29,017
-19.8%
0.00%
Q1 2021$341,000
+162.3%
36,184
+9.5%
0.00%
Q4 2020$130,000
+170.8%
33,042
+83.7%
0.00%
Q3 2020$48,000
-69.6%
17,989
-24.5%
0.00%
Q2 2020$158,0000.0%23,833
-12.4%
0.00%
Q1 2020$158,000
-25.8%
27,207
+14.5%
0.00%
Q4 2019$213,000
-39.8%
23,752
-42.0%
0.00%
Q3 2019$354,000
-6.6%
40,939
+20.5%
0.00%
Q2 2019$379,000
+290.7%
33,971
+366.9%
0.00%
Q1 2019$97,000
-76.7%
7,276
-72.9%
0.00%
Q4 2018$416,000
-28.0%
26,871
-33.8%
0.00%
Q3 2018$578,00040,5950.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,102,929$18,059,047,0004.95%
Svennilson Peter 3,102,934$18,059,0002.29%
Casdin Capital, LLC 2,270,000$13,211,0001.40%
FRAZIER MANAGEMENT LLC 2,061,758$11,999,0001.36%
Redmile Group, LLC 3,068,194$17,857,0000.50%
Alphabet Inc. 929,022$5,407,0000.36%
Bleichroeder LP 169,039$984,0000.26%
Leap Investments LP 14,400$84,0000.12%
DAFNA Capital Management LLC 50,000$291,0000.12%
Blackstone Inc. 2,567,445$14,943,0000.11%
View complete list of GRITSTONE ONCOLOGY INC shareholders